tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VCYT Stock Latest News

NCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim
The FlyNCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim
3d ago
VCYT
Veracyte Inc. Reports Robust Q3 Earnings Performance
PremiumCompany Announcements
Veracyte Inc. Reports Robust Q3 Earnings Performance
4d ago
VCYT
Veracyte rises 21.4%
PremiumThe Fly
Veracyte rises 21.4%
5d ago
VCYT
Cathie Wood Pours into Veracyte Stake ahead of Earnings Beat, Slashes Biotech Holdings
PremiumMarket News
Cathie Wood Pours into Veracyte Stake ahead of Earnings Beat, Slashes Biotech Holdings
5d ago
TXG
CRSP
Veracyte rises 26.4%
PremiumThe Fly
Veracyte rises 26.4%
5d ago
VCYT
Veracyte price target raised to $43 from $40 at Canaccord
PremiumThe FlyVeracyte price target raised to $43 from $40 at Canaccord
5d ago
VCYT
Veracyte price target raised to $48 from $42 at UBS
Premium
The Fly
Veracyte price target raised to $48 from $42 at UBS
5d ago
VCYT
Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
5d ago
VCYT
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target
PremiumRatings
Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target
5d ago
VCYT
Veracyte Reports Strong Q3 2025 Financial Performance
PremiumCompany Announcements
Veracyte Reports Strong Q3 2025 Financial Performance
5d ago
VCYT
Veracyte reports Q3 adjusted EPS 51c, consensus 32c
PremiumThe Fly
Veracyte reports Q3 adjusted EPS 51c, consensus 32c
6d ago
VCYT
Veracyte raises FY25 revenue view to $506M-$510M from $496M-$504M
PremiumThe Fly
Veracyte raises FY25 revenue view to $506M-$510M from $496M-$504M
6d ago
VCYT
Veracyte announces first publications using Afirma GRID research tool
PremiumThe FlyVeracyte announces first publications using Afirma GRID research tool
7d ago
VCYT
VCYT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VCYT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8d ago
VCYT
Veracyte initiated with a Hold at Canaccord
Premium
The Fly
Veracyte initiated with a Hold at Canaccord
21d ago
VCYT
Veracyte initiated with a Buy at Freedom Capital
PremiumThe Fly
Veracyte initiated with a Buy at Freedom Capital
25d ago
VCYT
Veracyte announces results from BALANCE trial of PAM50
PremiumThe Fly
Veracyte announces results from BALANCE trial of PAM50
1M ago
VCYT
Veracyte reports Phase 3 STAMPEDE trial finding published in Cell
PremiumThe Fly
Veracyte reports Phase 3 STAMPEDE trial finding published in Cell
2M ago
VCYT
Veracyte meets targeted enrollment for NIGHTINGALE trial
PremiumThe Fly
Veracyte meets targeted enrollment for NIGHTINGALE trial
3M ago
VCYT
Veracyte management to meet with Craig-Hallum
PremiumThe FlyVeracyte management to meet with Craig-Hallum
3M ago
VCYT
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns
Premium
Ratings
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns
3M ago
VCYT
Veracyte price target lowered to $28 from $29 at Morgan Stanley
Premium
The Fly
Veracyte price target lowered to $28 from $29 at Morgan Stanley
3M ago
VCYT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >